GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:16987180

From GONUTS
Jump to: navigation, search
Citation

Hager, AJ, Bolton, DL, Pelletier, MR, Brittnacher, MJ, Gallagher, LA, Kaul, R, Skerrett, SJ, Miller, SI and Guina, T (2006) Type IV pili-mediated secretion modulates Francisella virulence. Mol. Microbiol. 62:227-37

Abstract

Francisella tularensis are the causative agent of the zoonotic disease, tularaemia. Among four F. tularensis subspecies, ssp. novicida (F. novicida) is pathogenic only for immunocompromised individuals, while all four subspecies are pathogenic for mice. This study utilized proteomic and bioinformatic approaches to identify seven F. novicida secreted proteins and the corresponding Type IV pilus (T4P) secretion system. The secreted proteins were predicted to encode two chitinases, a chitin binding protein, a protease (PepO), and a beta-glucosidase (BglX). The transcription of F. novicida pepO and bglX was regulated by the virulence regulator MglA. Intradermal infection of mice with F. novicida mutants defective in T4P secretion system or PepO resulted in enhanced F. novicida spread to systemic sites. Infection with F. novicida pepO mutants also resulted in increased neutrophil infiltration into the mouse airways. PepO is a zinc protease that is homologous to mammalian endothelin-converting enzyme ECE-1. Therefore, secretion of PepO likely results in increased production of endothelin and increased vasoconstriction at the infection site in skin that limits the F. novicida spread. Francisella human pathogenic strains contain a mutation in pepO predicted to abolish its secretion. Loss of PepO function may have contributed to evolution of highly virulent Francisellae.

Links

PubMed Online version:10.1111/j.1365-2958.2006.05365.x

Keywords

Animals; Bacterial Proteins/genetics; Bacterial Proteins/metabolism; Cell Line; Cell Line, Tumor; Culture Media/metabolism; Fimbriae Proteins/genetics; Fimbriae Proteins/metabolism; Francisella/genetics; Francisella/metabolism; Francisella/pathogenicity; Genetic Complementation Test; Gram-Negative Bacterial Infections/microbiology; Humans; Macrophages/microbiology; Metalloproteases/genetics; Metalloproteases/metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Mutagenesis, Site-Directed/methods; Mutation/genetics; Reverse Transcriptase Polymerase Chain Reaction; Spleen/microbiology; Virulence/genetics; Virulence Factors/genetics; Virulence Factors/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

FRANO:Q09WI6

GO:0008237: metallopeptidase activity

ECO:0000315:

F

Figure 2: Mutant strains lacking pepO or expressing mutated pepO cannot cleave neuropeptide metenkephalin.

complete


See also

References

See Help:References for how to manage references in GONUTS.